Clinical and Immunologic Correlates of out-of-Specification Ciltacabtagene Autoleucel in Multiple Myeloma: A Univerisity of Arizona Analysis

Key Points

• Out-of-specification ciltacabtagene autoleucel shows varied clinical outcomes in multiple myeloma.
• Key immunologic correlates indicate significant changes in patient response.
• Observational analysis across a university medical setting identifies critical markers affecting therapy efficacy.
• Findings highlight the necessity for careful consideration of these correlates when administering treatment.